Page 146 - Read Online
P. 146

Ambe et al. Mini-invasive Surg 2018;2:37  I  http://dx.doi.org/10.20517/2574-1225.2018.45                                        Page 11 of 13


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   International Agency for Research on Cancer. World cancer report 2014. Available from: https://www.drugsandalcohol.ie/28525/1/
                   World%20Cancer%20Report.pdf. [Last accessed on 17 Oct 2018]
               2.   Gamboa A, Lin Q, Jin P, Zhou Y, Liu Q, et al. The descriptive epidemiology of gastrointestinal malignancies. In: Cai Q, El-Rayes BF,
                   Hao J, editors. Gastrointestinal malignancies: new innovative diagnostics and treatment. New Jersey: World Scientific; 2015. pp. 1-40.
               3.   Lung MS, Trainer AH, Campbell I, Lipton L. Familial colorectal cancer. Intern Med J 2015;45:482-91.
               4.   Wells K, Wise PE. Hereditary colorectal cancer syndromes. Surg Clin North Am 2017;97:605-25.
               5.   Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Update on hereditary colorectal cancer: improving the clinical utility of
                   multigene panel testing. Clin Colorectal Cancer 2018;17:e293-305.
               6.   Lynch HT, Lynch J. Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol 2000;18:19S-31S.
               7.   Planck M1, Rambech E, Möslein G, Müller W, Olsson H, et al. High frequency of microsatellite instability and loss of mismatch-repair
                   protein expression in patients with double primary tumors of the endometrium and colorectum. Cancer 2002;94:2502-10.
               8.   Papadopoulos N, Lindblom A. Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997;10:89-99.
               9.   Shia J, Ellis NA, Paty PB, Nash GM, Qin J, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpol-
                   yposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003;27:1407-17.
               10.  Malesci A, Laghi L, Bianchi P, Delconte G, Randolph A, et al. Reduced likelihood of metastases in patients with microsatellite-unstable
                   colorectal cancer. Clin Cancer Res 2007;13:3831-9.
               11.  Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syn-
                   drome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
               12.  Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, et al. A national cancer institute workshop on hereditary nonpol-
                   yposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
               13.  Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, et al. The reliability of immunohistochemistry as a prescreening
                   method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam
                   Cancer 2001;1:87-92.
               14.  Hampel H, Pearlman R, Beightol M, Zhao W, Jones D, et al. Assessment of tumor sequencing as a replacement for Lynch syndrome
                   screening and current molecular tests for patients with colorectal cancer. JAMA Oncol 2018;4:806-13.
               15.  Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, et al. Revised guidelines for the clinical management of Lynch syndrome
                   (HNPCC): recommendations by a group of European experts. Gut 2013;62:812-23.
               16.  Rau B, Angele M, Gonzalez-Moreno S, Kähler G, Langelotz C, et al. Gender-specific aspects in gastrointestinal medicine and surgery.
                   Viszeralmedizin 2014;30:133-5.
               17.  Möslein G, Ohmann C, Wenzel M. Prophylactic surgery for hereditary non-polyposis colorectal cancer. Chirurg 2005;76:1135-44. (in
                   German)
               18.  Schneider R, Fürst A, Möslein G. Gender-specific aspects of Lynch syndrome--an update. Z Gastroenterol 2015;53:789-93. (in German)
               19.  Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision
                   and central ligation--technical notes and outcome. Colorectal Dis 2009;11:354-64.
               20.  Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision,
                   1978-1997. Arch Surg 1998;133:894-9.
               21.  Hazebroek EJ; Color Study Group. COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer.
                   Surg Endosc 2002;16:949-53.
               22.  Kneist W, Hanke L, Kauff DW, Lang H. Surgeons’ assessment of internal anal sphincter nerve supply during TaTME - inbetween ex-
   141   142   143   144   145   146   147   148   149   150   151